European Heart Journal Cardiovascular Pharmacotherapy Impact Factor, Quartile, Indexing, Ranking

European Heart Journal Cardiovascular Pharmacotherapy (EHJCP) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Oxford University Press. The Print-ISSN of European Heart Journal Cardiovascular Pharmacotherapy is 2055-6837 and its abbreviation is Eur Heart J Cardiovasc Pharmacother.

The Publicaiton fees (APC) is 3828.72 EUR.

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area. While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.

• Journal Website
• PubMed
• Scopus
• SCImago